ASX:NASDAQ:TLX: Telix Appoints David Gill as Non-Executive Director General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: Telix Resubmits NDA to FDA for Pixclara Brain Cancer Imaging General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: ProstACT Global Phase 3 (Part 1) Results Presentation General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: ProstACT Global Phase 3 (Part 1) Achieves Primary Objectives General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: Appendix 4G and 2025 Corporate Governance Statement General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: 2025 Full Year Results Presentation General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: 2025 Full Year Results Announcement General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX: Appendix 4E and 2025 Annual Report General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Telix Submits EU MAA for TLX101-Px Brain Cancer Imaging General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq: TLX - Chair Resignation, Dr Mark Nelson appointed Interim Chair General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Telix Achieves FY25 Guidance - US$804M, Q4 Growth General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq: TLX - Chinese NMPA Accepts New Drug Application for Illuccix General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Telix JP Morgan Healthcare Conference 2026 Presentation General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Precision Medicine Portfolio Update General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - ProstACT Global Study Status General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - 1st Patient Dosed in ProstACT Global Randomized Tx Expansion General Announcement Filing viewer · member access Original SGX announcement
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - CMS Grants Transitional Pass-Through Status for Gozellix General Announcement Filing viewer · member access Original SGX announcement
Telix and FDA Agree Resubmission Pathway for Pixclara NDA General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq: TLX - Telix Provides Regulatory Update on TLX250-CDx General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Telix H1 2025 Results Presentation General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Telix H1 2025 Results Announcement General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq: TLX - Telix H1 2025 Appendix 4D and Interim Report General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq: TLX - Historical Financials in USD and H12025 OPEX (Unaudited) General Announcement Filing viewer · member access Original SGX announcement
ASX:TLX; Nasdaq:TLX - Telix Reports US$204M Q2 Revenue, Up 63% YOY General Announcement Filing viewer · member access Original SGX announcement